Prevacid Strong Switch Candidate, Experts Say; TAP Works on Follow-on
This article was originally published in The Tan Sheet
Prevacid's bioavailability combined with the strong safety profile of the PPI class make it a good candidate for an Rx-to-OTC switch, experts say
You may also be interested in...
Novartis is developing TAP's Prevacid prescription heartburn and GERD therapy for a 2009 switch to OTC status, the firms announced Dec. 20
Abbott Labs plans to counter the launch of Prilosec OTC with a broad direct-to-consumer advertising campaign for its Rx proton pump inhibitor Prevacid
Perrigo promotes in pricing, planning